Moderna will build an RNA vaccine research and production facility in the UK

American biotechnology company Moderna will build a research and production center dedicated to messenger RNA vaccines in the United Kingdom, the British government announced on Wednesday 22 June, that it intends to prepare “For future pandemics”,

This agreement, the financial terms of which have not been disclosed, is intended to provide access to patients from the British Public Health Service “For the next generation of vaccines and therapies”, the Health Ministry said in a statement. It provides a center for research and development on RNA vaccines, a center for the production of vaccines, and for conducting a large portion of clinical trials on British soil. Government emphasizes role “axis” of this technology in the fight against the epidemic, and its “Potential to enable breakthroughs with respect to certain types of diseases, such as cancer, influenza, dementia or heart disease”,

Manufacturing should begin this year for the first vaccines produced in 2025. “The center will be able to rapidly ramp up production in the event of a health emergency, strengthening the UK’s ability to respond to future pandemics”It is specified. “Our investment will secure vaccines against the most dangerous viruses, keeping us at the forefront of the fight against future threats”Prime Minister Boris Johnson, quoted in the press release, insisted.

One of the countries hardest-hit by the Covid-19 pandemic with nearly 180,000 deaths, the United Kingdom has purchased vaccines in recent years, including RNA technologies purchased from Pfizer and Moderna, while it has been mainly focused on the more classic AstraZeneca/ Manufactures Oxford Serum.

See also  85-year-old grandfather has millions of views on Tickcock

You May Also Like

About the Author: Forrest Morton

Organizer. Zombie aficionado. Wannabe reader. Passionate writer. Twitter lover. Music scholar. Web expert.

Leave a Reply

Your email address will not be published.